Novel RET Fusion <i>RET-SEPTIN9</i> Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma
Angela Mweempwa, Huiling Xu, Joseph H.A. Vissers, Richard W. Tothill, Andrew Pattison, Andrew Fellowes, David M. Thomas, Gary Richardson, Rodney J. Hicks, Sean M. Grimmond, Stephen B. Fox, Stephen J. Luen, Jayesh Desai, Benjamin Solomon
Topics & Concepts
PheochromocytomaCancer researchProto-Oncogene Proteins c-retMedicineFusionInternal medicineChemistryOncologyPhilosophyReceptorLinguisticsGlial cell line-derived neurotrophic factorNeurotrophic factorsCancer, Hypoxia, and MetabolismAdrenal and Paraganglionic TumorsNeuroblastoma Research and Treatments